Qube Research & Technologies (QRT)
MBIO icon

Qube Research & Technologies (QRT)’s Mustang Bio MBIO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-70
Closed -$25K – 2785
2022
Q3 		$25K Sell
70
-3
-4% -$1.39K ﹤0.01% 2270
2022
Q2 		$32K Buy
+73
New +$40.4K ﹤0.01% 2199

Other funds holding MBIO

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MBIO Position: Q4 2022 in Review

Qube Research & Technologies (QRT) sold out of Mustang Bio (MBIO) in Q4 2022, closing a stake of 70 shares — an estimated $25K sold.

Qube Research & Technologies (QRT) first reported a position in MBIO in Q2 2022 and held it in 2 quarters. The position peaked at $32K in Q2 2022. 60 funds tracked by Wall St. Rank hold MBIO as of Q4 2022.

  • Qube Research & Technologies (QRT) reported no remaining Mustang Bio position as of Q4 2022 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 70 Mustang Bio shares in Q4 2022, an estimated $25K.
  • Qube Research & Technologies (QRT) first reported a position in Mustang Bio in Q2 2022 and held it in 2 quarters.
  • Qube Research & Technologies (QRT)'s Mustang Bio position peaked at $32K in Q2 2022.
  • 60 funds tracked by Wall St. Rank held Mustang Bio as of Q4 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.